Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version of the study record published with minor edits.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.0, indicating a new page revision or metadata update rather than a change to study details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now indicates that recruitment has ended for the study, meaning participants can no longer enroll. It also adds new help and guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label from v3.5.5 to v3.6.0, with a minor formatting tweak to the Intervention/Treatment label.SummaryDifference0.5%

- Check58 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page. No study details, outcomes, or eligibility criteria appear to have been changed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision label updated to v3.5.4, indicating a new version of the page. The change reflects an incremental update to the page metadata rather than substantive content changes.SummaryDifference0.1%

- Check101 days agoChange DetectedUpdated the site’s revision/version indicator from **v3.5.0** to **v3.5.3**, reflecting a maintenance or release update rather than a change to the clinical trial record.SummaryDifference0.1%

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.